Figure 3 | Scientific Reports

Figure 3

From: Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma

Figure 3

Effects of LC28-0126 on airway responsiveness and histological changes in OVALPS-OVA mice.

(a) Airway responsiveness in LC28-0126-treated OVALPS-OVA mice. Bars represent mean ± SEM from 8 mice per group. #p < 0.05 vs. SV or Control; *p < 0.05 vs. OLV. (b) Histopathological changes in airway in LC28-0126-treated OVALPS-OVA mice. Scale bars indicate scale of 50 μm.

Back to article page